Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beijing Foyou Pharma CoSHSE:601089 -0.30%55 Pretax Margin % is 12.83% as of Mar. 2026, which is 8% below its 10-year median of 13.91. GuruFocus rates SHSE:601089 with a GF Score™ of 55/100 and a GF Value™ of ¥16.99 (Fairly Valued). The stock has 1 warning sign investors should review. Among 959 Drug Manufacturers companies, Beijing Foyou Pharma Co ranks better than 67.47% on this metric.
The historical rank and industry rank for Beijing Foyou Pharma Co's Pretax Margin % or its related term are showing as below:
SHSE:601089'
s Pretax Margin % Range Over the Past 10 Years
Min: 10.18 Med: 13.91 Max: 16.44
Current: 13.86
SHSE:601089's Pretax Margin % is ranked better than 67.47% of 959
companies
in the Drug Manufacturers industry
Industry Median: 7.28
vs SHSE:601089: 13.86
Beijing Foyou Pharma Co (SHSE:601089) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Beijing Foyou Pharma Co Pretax Margin % Related Terms
Beijing Foyou Pharma Co Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:601089 vs ZTS, UTHR: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Foyou Pharma Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Foyou Pharma Co Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Beijing Foyou Pharma Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Beijing Foyou Pharma Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Foyou Pharma Co (SHSE:601089) has a Pretax Margin % of 12.83% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Beijing Foyou Pharma Co and its competitors. This is near median its historical median of 13.91. Over the past decade, Beijing Foyou Pharma Co's Pretax Margin % has ranged from 10.18 to 16.44. According to the industry distribution chart, Beijing Foyou Pharma Co ranks #312 out of 959 companies in the Drug Manufacturers industry, placing it in the top 32.5%.
Is Beijing Foyou Pharma Co's Pretax Margin % too high?
Beijing Foyou Pharma Co's current Pretax Margin % of 12.83% is near median its 10-year median of 13.91. Over the past 10 years, this metric has ranged from a low of 10.18 to a high of 16.44. The Drug Manufacturers industry median Pretax Margin % is 7.28. Beijing Foyou Pharma Co's value of 12.83% is 76.2% above this industry median. Based on the distribution chart, Beijing Foyou Pharma Co ranks #312 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Beijing Foyou Pharma Co has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Beijing Foyou Pharma Co's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Beijing Foyou Pharma Co ranks #312 out of 959 companies for Pretax Margin %. This puts Beijing Foyou Pharma Co in the upper half of its industry. The industry median Pretax Margin % is 7.28. Beijing Foyou Pharma Co's value of 12.83% is 76.2% above this benchmark. Historically, Beijing Foyou Pharma Co's own Pretax Margin % has ranged from 10.18 to 16.44 over the past decade. While the company's 10-year median is 13.91 vs. the industry median of 7.28, Beijing Foyou Pharma Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.28, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Foyou Pharma Co's current Pretax Margin % of 12.83% is 76.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Beijing Foyou Pharma Co and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Foyou Pharma Co's current Pretax Margin % is 12.83%, which is near median its own 10-year median of 13.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Foyou Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Foyou Pharma Co (SHSE:601089) is currently considered Fairly Valued. The stock's GF Value™ is ¥16.99, compared to a current price of ¥16.80 — trading 1.1% below its estimated fair value. The current Pretax Margin % is 12.83%, which is near median its 10-year median of 13.91 and 76.2% above the Drug Manufacturers industry median of 7.28. Beijing Foyou Pharma Co's overall GF Score™ is 55/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Beijing Foyou Pharma Co (SHSE:601089), the current Pretax Margin % is 12.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Foyou Pharma Co (SHSE:601089) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Foyou Pharma Co stock appears to be undervalued.
The current stock price of ¥16.80 is trading 1.1% below its estimated GF Value™ of ¥16.99.
GuruFocus considers Beijing Foyou Pharma Co to be Fairly Valued.
Key valuation signals for SHSE:601089:
Pretax Margin %: 12.83% (near median its 10-year median of 13.91)
GF Value™: ¥16.99 vs. price of ¥16.80 (1.1% below fair value)
Industry Position: 76.2% above the Drug Manufacturers median (#312 of 959)
No single metric tells the full story. See the SHSE:601089 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:601089 has been successfully added to your 
